Zocor, Zoloft And Pravachol Will Be Key Generic Switches For Medco In ’06
Executive Summary
Medco sees a significant opportunity for growth in 2006 generic switches, Group President-National Accounts Timothy Wentworth says
You may also be interested in...
Teva/Ivax Merger Will Create Significant Pricing Flexibility In Generics
Teva is prepared to leverage its $7.4 bil. acquisition of Ivax to offer the lowest prices on generic drugs "if need be," Ivax Chairman Phillip Frost said July 26 during a call regarding the deal
Teva/Ivax Merger Will Create Significant Pricing Flexibility In Generics
Teva is prepared to leverage its $7.4 bil. acquisition of Ivax to offer the lowest prices on generic drugs "if need be," Ivax Chairman Phillip Frost said July 26 during a call regarding the deal
PBMs Eye Acquisitions In “Target-Rich Environment”
Medco could seek to grow through acquisitions that cost less than $300 mil